Boswellic acids extract attenuates pulmonary fibrosis induced by bleomycin and oxidative stress from gamma irradiation in rats

Chinese Medicine

Volumn 6, Issue , 2011, Pages

  Ali, Eman N ^a   Mansour, Somaya Z ^a  

^a NATIONAL CENTER FOR RADIATION RESEARCH AND TECHNOLOGY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; BOSWELLIC ACID; CESIUM 137; HYDROXYPROLINE; LACTATE DEHYDROGENASE; LIPID PEROXIDE; LIPOXYGENASE; SODIUM CHLORIDE; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANADA; CONTROLLED STUDY; ENZYME ACTIVITY; EOSINOPHIL; FIBROBLAST; GAMMA IRRADIATION; HISTOLOGY; LACTATE DEHYDROGENASE BLOOD LEVEL; LUNG FIBROSIS; LUNG LAVAGE; MACROPHAGE; MALE; NEUTROPHIL; NONHUMAN; OXIDATIVE STRESS; RAT; SUPPRESSOR CELL;

EID: 80053350634     PISSN: None     EISSN: 17498546     Source Type: Journal    
DOI: 10.1186/1749-8546-6-36     Document Type: Article

References (93)

1. Crystal RG, Bitterman PB, Mossman B, Schwarz MI, Sheppard D, Almasy L, Chapman HA, Friedman SL, King TE, Leinwand LA. Future research directions in idiopathic pulmonary fibrosis: summary of a National Heart, Lung, and Blood Institute working group. Am J Respir Crit Care Me 2002, 166:236-246.
2. American Thoracic Society Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement: American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med 2000, 161:646-664. American Thoracic Society.
3. Ziesche R, Hofbauer E, Wittmann K, Petkov V, Block LH. A preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis. N Engl J Med 1999, 341:1264-1269. 10.1056/NEJM199910213411703, 10528036.
4. Gauldie J. inflammatory mechanisms are a minor component of the pathogenesis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2002, 165:1205-1206. 10.1164/rccm.2202054, 11991866.
5. Keane MP, Strieter RM. The importance of balanced pro-inflammatory and anti-inflammatory mechanisms in diffuse lung disease. Respir Res 2002, 3:5. 10.1186/rr177, 64816, 11806840.
6. Kelly M, Kolb M, Bonniaud P, Gauldie J. A re-evaluation of fibrogenic cytokines in lung fibrosis. Curr Pharm Des 2003, 9:39-49. 10.2174/1381612033392341, 12570673.
7. Sime PJ, Xing Z, Graham FL, Csaky KG, Gauldie J. Adenovector-mediated gene transfer of active transforming growth factor-beta1 induces prolonged severe fibrosis in rat lung. J Clin Invest 1997, 100:768-776. 10.1172/JCI119590, 508247, 9259574.
8. Wang Q, Wang Y, Hyde DM, Gotwals PJ, Koteliansky VE, Ryan ST, Giri SN. Reduction of bleomycin induced lung fibrosis by transforming growth factor beta soluble receptor in hamsters. Thorax 1999, 54:805-812. 10.1136/thx.54.9.805, 1745567, 10456973.
9. Bazzoni F, Beutler B. The tumor necrosis factor ligand and receptor families. N Engl J Med 1996, 334:1717-172. 10.1056/NEJM199606273342607, 8637518.
10. Piguet PF, Ribaux V, Karpuz G, Grau E, Kapanci Y. Expression and localization of tumor necrosis factor-alpha and its mRNA in idiopathic pulmonary fibrosis. Am J Pathol 1993, 143(3):651-655. 1887194, 8362967.
11. Piguet PF, Collart MA, Grau GE, Kapanci Y, Vassalli P. Tumor necrosis factor/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis. J Exp Med 1989, 170(3):655-663. 10.1084/jem.170.3.655, 2189418, 2475571.
12. Piguet PF, Vesin C. Treatment by human recombinant soluble TNF receptor of pulmonary fibrosis induced by bleomycin or silica in mice. Eur Respir J 1994, 7(3):515-518. 10.1183/09031936.94.07030515, 7516893.
13. Ortiz L, Lasky J, Lungarella G, Cavarra E, Martorana P, Banks W, Peschon J, Schmidts H, Brody A, Friedman M. Upregulation of the p75 but not the p55 TNF-alpha receptor mRNA after silica and bleomycin exposure and protection from lung injury in double receptor knockout mice. Am J Respir Cell Mol Biol 1999, 20:825-833.
14. Liu JY, Brass DM, Hoyle GW, Brody AR. TNF-a receptor knockout mice are protected from the fibroproliferative effects of inhaled asbestos fibers. Am J Pathol 1998, 153:1839-1847. 10.1016/S0002-9440(10)65698-2, 1866331, 9846974.
15. Ortiz LA, Lasky J, Holian RFH, Hoyle GW, Banks W, Peschon JJ, Brody AR, Lungarella G, Friedman M. Expression of TNF and the necessity of the receptors in bleomycin-induced lung injury in mice. Exp Lung Res 1998, 24:721-743. 10.3109/01902149809099592, 9839161.
16. Fujita M, Shannon JM, Irvin CG, Fagan KA, Cool C, Augustin A, Mason RJ. Overexpression of tumor necrosis factor-a produces and increase in lung volumes and pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 2001, 280:L39-L49.
17. Ahmed RG. Damage pattern as function of various types of radiations. Medical Journal of Islamic World Academy of Sciences 2005, 15:4. 135-147.
18. Sime PJ, Marr RA, Gauldie D, Xing Z, Hewlett BR, Graham FL, Gauldie J. Transfer of tumor necrosis factor-α to rat lung induces severe pulmonary inflammation and patchy interstitial fibrogenesis with induction of transforming growth factor-b1 and my oblasts. Am J Pathol 1998, 153:825-832. 10.1016/S0002-9440(10)65624-6, 1853002, 9736031.
19. Broekelmann TJ, Limper AH, Colby TV, McDonald JA. Transforming growth factor beta 1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis. Proc Natl Acad Sci USA 1991, 88:6642-6646. 10.1073/pnas.88.15.6642, 52144, 1862087.
20. Han R. Highlight on the studies of anticancer drugs derived from plants in China. Stem Cells 1994, 12:53-63. 10.1002/stem.5530120110, 8142920.
21. Reddy GK, Chandrakasan G, Dhar SC. Studies on the metabolism of glycosaminoglycans under the influence of new herbal anti-inflammatory agents. Biochem Pharmacol 1989, 38:3527-3534. 10.1016/0006-2952(89)90124-X, 2818645.
22. Safayhi H, Mack T, Sabieraj J, Anazodo MI, Subramanian LR, Ammon HP. Boswellic acids: novel, specific, nonredox inhibitors of 5-lipoxygenase. J Pharmacol Exp Ther 1992, 261:1143-1146.
23. Ammon HP, Safayhi H, Mack T, Sabieraj J. Mechanism of antiinflammatory actions of curcumine and boswellic acids. J Ethnopharmacol 1992, 38:113-119.
24. Safayhi H, Sailer ER, Ammon HP. Mechanism of 5-lipoxygenase inhibition by acetyl-11-keto-beta-boswellic acid. Mol Pharmacol 1995, 47:1212-1216.
25. Safayhi H, Rall B, Sailer ER, Ammon HP. Inhibition by boswellic acids of human leukocyte elastase. J Pharmacol Exp Ther 1997, 281:460-463.
26. Kapil A, Moza N. Anticomplementary activity of boswellic acids--an inhibitor of C3-convertase of the classical complement pathway. Int J Immunopharmacol 1992, 14:1139-1143. 10.1016/0192-0561(92)90048-P, 1452399.
27. Cooper JA. Pulmonary fibrosis: pathways are slowly coming into light. Am J Respir Cell Mol Biol 2000, 22:520-523.
28. Fell CD, Martinez FJ, Liu LX, Murray S, Han MK, Kazerooni EA, Gross BH, Myers J, Travis WD, Colby TV, Toews GB, Flaherty KR. Clinical predictors of a diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2010, 15;181(8):832-7.
29. Upaganlawar A, Ghule B. Pharmacological Activities of Boswellia serrata Roxb. Mini Review. Ethnobotanical Leaflets 2009, 13:766-774.
30. Gupta V, Parihar A, Gupta S, Ludtke R, Safayhi H, Ammon HP. Effect of Boswellia serrata gum resin in patient with bronchial asthma: Results of a double blind, placebo controlled 6 week clinical study. Eur J Med Res 1998, 3(11):511-514.
31. Massey TE, Leeder RG, Rafeiro E, Brien JF. Mechanisms in the pathogenesis of amiodarone - induced pulmonary toxicity. Can J Physiol Pharmacol 1995, 73:1675-1685. 10.1139/y95-730, 8834480.
32. Sheppard D. Transforming growth factor beta: a central modulator of pulmonary and airway inflammation and fibrosis. Proc Am Thorac Soc 2006, 3(5):413-417. 10.1513/pats.200601-008AW, 2658705, 16799084.
33. Pittet JF, Griffiths MJ, Geiser T, Kaminski N, Dalton SL, Huang X, Brown LA, Gotwals PJ, Koteliansky VE, Matthay MA. TGF-beta is a critical mediator of acute lung injury. J Clin Invest 2001, 107:1537-1544. 10.1172/JCI11963, 200192, 11413161.
34. Khalil N, Xu YD, O'Connor R, Duronio V. Proliferation of pulmonary interstitial fibroblasts is mediated by transforming growth factor-beta1-induced release of extracellular fibroblast growth factor-2 and phosphorylation of p38. J Biol Chem 2005, 30;280(52):43000-430009.
35. Biswas S, Guix M, Rinehart C, Dugger TC, Chytil A, Moses HL, Freeman ML, Arteaga CL. Inhibition of TGF-beta with neutralizing antibodies prevents radiation-induced acceleration of metastatic cancer progression. J Clin Invest 2007, 117(5):1305-1313. 10.1172/JCI30740, 1838926, 17415413.
36. Liu F. PCTA: A new player in TGF-beta signaling. Sci Signal 2008, 1(46):49.
37. Latella G, Sferra R, Vetuschi A, Zanninelli G, D'Angelo A, Catitti V, Caprilli R, Gaudio E. Prevention of colonic fibrosis by Boswellia and Scutellaria extracts in rats with colitis induced by 2,4,5-trinitrobenzene sulphonic acid. Eur J Clin Invest 2008, 38(6):410-420. 10.1111/j.1365-2362.2008.01955.x, 18489401.
38. Tran TT, Ma JY, Li Z, Chakravarty S, McEnroe G, Murphy A, Dugar S, Lam A, Liu DY, Scheiner G. A small molecule orally active TGF-b-RI kinase inhibitor, SD-208, reduces profibrotic gene expression and biochemical and morphological markers of fibrosis in the rat bleomycin model of pulmonary fibrosis. Am J Respir Crit Care Med 2003, 167:A666.
39. Fujita M, Shannon JM, Morikawa O, Gauldie J, Hara N, Mason RJ. Overexpression of TNF-alpha diminishes pulmonary fibrosis induced by bleomycin or TGF-beta. Am J Respir Cell Mol Biol 2003, 29(6):669-676. 10.1165/rcmb.2002-0046OC, 12816730.
40. Yan X, Liu Z, Chen Y. TNF: Regulation of TGF-beta signaling by Smad7. Acta Biochim Biophys Sin (Shanghai) 2009, 41(4):263-272.
41. Kuroki M, Noguchi Y, Shimono M, Tomono K, Tashiro T, Obata Y, Nakayama E, Kohno S. Repression of bleomycin-induced pneumopathy by TNF. J Immunol 2003, 170(1):567-574.
42. Laizo A. Chronic obstructive pulmonary disease - a review. Rev Port Pneumol 2009, 15(6):1157-1166.
43. Shankar PS. Recent advances in the assessment and management of chronic obstructive pulmonary disease. Indian J Chest Dis Allied Sci 2008, 50(1):79-88.
44. Oudijk EJ, Lammers JW, Koenderman L. Systemic inflammation in chronic obstructive pulmonary disease. Eur Respir J Suppl 2003, 46:5s-13s.
45. Cuzzocrea S, Ronchetti S, Genovese T, Mazzon E, Agostini M, Di Paola R, Esposito E, Muià C, Nocentini G, Riccardi C. Genetic and pharmacological inhibition of GITR-GITRL interaction reduces chronic lung injury induced by bleomycin instillation. FASEB J 2007, 21(1):117-29.
46. Claudia C. Advances in mechanisms of repair and remodeling in acute lung injury. Intensive Care Medicine 2008, 34(4):619-630. 10.1007/s00134-007-0963-x, 18264692.
47. Cortijo J, Cerdá-Nicolás M, Serrano A, Bioque G, Estrela JM, Santangelo F, Esteras A, Llombart-Bosch A, Morcillo EJ. Attenuation by oral N-acetylcysteine of bleomycin-induced lung injury in rats. Eur Respir J 2001, 17(6):1228-35. 10.1183/09031936.01.00049701, 11491169.
48. Badria FA, Mikhaeil BR, Maatooq GT, Amer MM. Immunomodulatory Triterpenoids from the Oleogum Resin of Boswellia carterii Birdwood. Z Naturforsch [C] 2003, 58:505-516.
49. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951, 193:265.
50. Spom MB, Roberts AB. "The Transforming Growth Factor-βs" In Peptide Growth Factors and Their Receptors I. 1990, 419. Springer-Vertag, New York.
51. Carswell EA, Old LJ, Kassel RL, Green S, Fiore N, Williamson B. An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA 1975, 72(9):3666-3670. 10.1073/pnas.72.9.3666, 433057, 1103152.
52. Gaffney BJ. Lipoxygenases: Structural principles and spectroscopy. Annu Rev Biophys Biomol Struct 1996, 25:431-459. 10.1146/annurev.bb.25.060196.002243, 8800477.
53. Thrall R, McCormack J, Jack R, Mc Reynolds R, Ward P. Bleomycin-induced pulmonary fibrosis in the rat: inhibition by indomethacin. Am J Pathol 1979, 95:117. 2042298, 86304.
54. Yoshioka T, Kawada K, Shimada T, Mori M. Lipid peroxidation in maternal and cord blood and protective mechanism against activated oxygen toxicity in the blood. Am J Obstet Gynecol 1979, 135:372-376.
55. Beutler E, Duron O, Kelly BM. Improved method of the determination of blood glutathione. J Lab Clin Med 1963, 61(5):882-890.
56. Pigeolot E, Corbisier P, Houbion A, Lambert D, Michiels C, Raes M. Glutathione peroxidase, superoxide dismutase and catalase inactivation by peroxide and oxygen derived radicals. Mechanisms of Ageing and Development 1990, 51:283-297. 10.1016/0047-6374(90)90078-T, 2308398.
57. Minami M, Yoshikawa H. A simplified assay method of superoxide dismutase. Clinica Chimica Acta 1979, 92:337-342.
58. Sinha AK. Colorimetric assay of catalase. Anal Biochem 1972, 47:389-394. 10.1016/0003-2697(72)90132-7, 4556490.
59. Drury RA, Wallington EA. Carlton's histological techniques. 1976, 139-142. London: Oxford University Press, 6.
60. Ammon HP, Mack T, Singh GB, Safayhi H. Inhibition of leukotriene B4 formation in rat peritoneal neutrophils by an ethanolic extract of the gum resin exudate of Boswellia serrata. Planta Med 1991, 57(3):203-207. 10.1055/s-2006-960074, 1654575.
61. Ammon HP. Modulation of the immune system by Boswellia serrata extracts and boswellic acids. Phytomedicine 2010, 17(11):862-867. 10.1016/j.phymed.2010.03.003, 20696559.
62. Crystal RG, Bitterman PB, Mossman B, Schwarz MI, Sheppard D, Almasy L, Chapman HA, Friedman SL, King TE, Leinwand LA. Future research directions in idiopathic pulmonary fibrosis: summary of a National Heart, Lung, and Blood Institute working group. Am J Respir Crit Care Med 2002, 166:236-246. 10.1164/rccm.2201069, 12119236.
63. Cutroneo KR, White SL, Phan SH, Ehrlich HP. Therapies for bleomycin induced lung fibrosis through regulation of TGF-beta1 induced collagen gene expression. J Cell Physiol 2007, 211(3):585-589. 10.1002/jcp.20972, 17387717.
64. Martin M, Lefaix J, Delanian S. TGF-beta1 and radiation fibrosis: a master switch and a specific therapeutic target. Int J Radiat Oncol Biol Phys 2000, 47:277-290. 10.1016/S0360-3016(00)00435-1, 10802350.
65. Wang R, Ibarra-Sunga O, Verlinski L, Pick R, Uhal BD. Abrogation of bleomycin-induced epithelial apoptosis and lung fibrosis by captopril or by a caspase inhibitor. Am J Physiol Lung Cell Mol Physiol 2000, 279(1):L143-151.
66. Kreydiyyeh SI, Riman S, Serhan M, Kassardjian A. TNF-alpha modulates hepatic Na+-K+ ATPase activity via PGE2 and EP2 receptors. Prostaglandins Other Lipid Mediat 2007, 83(4):295-303. 10.1016/j.prostaglandins.2007.02.003, 17499749.
67. Failla M, Genovese T, Mazzon E, Fruciano M, Fagone E, Gili E, Barera A, La Rosa C, Conte E, Crimi N, Cuzzocrea S, Vancheri C. 3.16,16-Dimethyl prostaglandin E2 efficacy on prevention and protection from bleomycin-induced lung injury and fibrosis. Am J Respir Cell Mol Biol 2009, 41(1):50-58. 10.1165/rcmb.2007-0438OC, 19059888.
68. Travis WD, Matsui K, Moss J, Ferrans VJ. Idiopathic nonspecific interstitial pneumonia: Prognostic significance of cellular and fibrosing patterns: Survival comparison with usual interstitial pneumonia and desquamative interstitial pneumonia. Am J Surg Pathol 2000, 24(1):19-33. 10.1097/00000478-200001000-00003, 10632484.
69. Kim KH, Maldonado F, Ryu JH, Eiken PW, Hartman TE, Bartholmai BJ, Decker PA, Yi ES. Iron deposition and increased alveolar septal capillary density in nonfibrotic lung tissue are associated with pulmonary hypertension in idiopathic pulmonary fibrosis. Respir Res 2010, 14:11:37.
70. Ammon HP, Mack T, Singh GB, Safayhi H. Inhibition of leukotriene B4 formation in rat peritoneal neutrophils by an ethanolic extract of the gum resin exudate of Boswellia serrata. Planta Med 1991, 57(3):203-207. 10.1055/s-2006-960074, 1654575.
71. Syrovets T, Büchele B, Krauss C, Laumonnier Y, Simmet T. Acetyl-boswellic acids inhibit lipopolysaccharide-mediated TNF-alpha induction in monocytes by direct interaction with Ikappa B kinases. J Immunol 2005, 1;174(1):498-506.
72. Kaplan M, Mutlu EA, Benson M, Fields JZ, Banan A, Keshavarzian A. Use of herbal preparations in the treatment of oxidant-mediated inflammatory disorders. Complement Ther Med 2006, 15(3):207-16.
73. Kinnula VL, Crapo JD, Raivio KO. Generation and disposal of reactive oxygen metabolites in the lung. Lab Invest 1995, 73(1):3-19.
74. Levis J, Loi R, Butnor KJ, Vacek P, Steele C, Mossman BT, Weiss DJ. Decreased asbestos-induced lung inflammation and fibrosis after radiation and bone marrow transplant. Am J Respir Cell Mol Biol 2008, 38(1):16-25. 2176130, 17673685.
75. Vujasovic Z, Anscher MS, Feng Q, Rabbani ZN, Amin K, Samulski TS, Dewhirst MW, Haroon ZA. Radiation-induced hypoxia may perpetuate late normal tissue injury. Int J Radiat Oncol Biol Phys 2001, 4:851-855.
76. Cooke KR, Hill GR, Gerbitz A, Kobzik L, Martin TR, Crawford JM, Brewer JP, Ferrara JLM. Tumor Necrosis factor-α neutralization reduces lung injury after experimental allogeneic bone marrow transplantation. Transplantation 2000, 70:272-279. 10.1097/00007890-200007270-00006, 10933148.
77. Yanik G, Hellerstedt B, Custer J, Hutchinson R, Kwon D, Ferrara JLM, Uberti J, Cooke KR. Etanercept (Enbrel) administration for idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2002, 8:395-400. 10.1053/bbmt.2002.v8.pm12171486, 12171486.
78. Gerbitz A, Nickiloff BJ, Olkiewicz K, Willmarth NE, Hildebrandt G, Liu C, Kobzik L, Eissner G, Holler E, Ferrara JLM. A role for tumor necrosis factor-α- mediated endothelial apoptosis in the development of experimental idiopathic pneumonia syndrome. Transplantation 2004, 78:494-502.
79. Gerbitz A, Ewing P, Olkiewicz K, Willmarth NE, William D, Hildebrandt G, Wilke A, Lie C, Eissner G, Andreesen R. A role for CD54 (intercellular adhesion molecule-1) on leukocyte recruitment to the lung during the development of experimental idiopathic pneumonia syndrome. Transplantation 2005, 79:536-542. 10.1097/01.TP.0000151763.16800.B0, 15753842.
80. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002, 26;420(6917):860-867.
81. Maderna P, Godson C. Phagocytosis of apoptotic cells and the resolution of inflammation. Biochim Biophys Acta 2003, 20;1639(3):141-51.
82. Vuokko L, Kinnula CL, Fattman RJT, Tim DO. Oxidative Stress in Pulmonary Fibrosis: A Possible Role for Redox Modulatory Therapy. Am J Respir Crit Care Med 2005, 172:417-422. 10.1164/rccm.200501-017PP, 2718525, 15894605.
83. Ming L, Sandra MJ, Marc Peters G, Thomas GB. Nuclear localization of 5-lipoxygenase as a determinant of leukotriene B4 synthetic capacity. Proc Natl Acad Sci USA 2003, 100(21):12165-12170. 10.1073/pnas.2133253100, 218730, 14530386.
84. Werz O. 5-lipoxygenase: cellular biology and molecular pharmacology. Curr Drug Targets Inflamm Allergy 2002, 1(1):23-44. 10.2174/1568010023344959, 14561204.
85. Lakari E, Paakko P, Pietarinen-Runtti P, Kinnula VL. Manganese superoxide dismutase and catalase are coordinately expressed in the alveolar region in chronic interstitial pneumonias and granulomatous diseases of the lung. Am J Respir Crit Care Med 2000, 161:615-621.
86. Avissar N, Finkelstein JN, Horowitz S, Willey JC, Coy E, Frampton MW, Watkins RH, Khullar P, Xu YL, Cohen HJ. Extracellular glutathione peroxidase in human lung epithelial lining fluid and in lung cells. Am J Physiol 1996, 270:L173-L182.
87. Fattman CL, Schaefer LM, Oury TD. Extracellular superoxide dismutase in biology and medicine. Free Radic Biol Med 2003, 35:236-256. 10.1016/S0891-5849(03)00275-2, 12885586.
88. Zhao J, Shi W, Wang YL, Chen H, Bringas P, Datto MB, Frederick JP, Wang XF, Warburton D. Smad3 deficiency attenuates bleomycin-induced pulmonary fibrosis in mice. Am J Physiol Lung Cell Mol Physiol 2002, 282:L585-L593.
89. Thannickal VJ, Toews GB, White ES, Lynch JP, Martinez FJ. Mechanisms of pulmonary fibrosis. Annu Rev Med 2004, 55:395-417. 10.1146/annurev.med.55.091902.103810, 14746528.
90. Bellocq A, Azoulay E, Marullo S, Flahault A, Fouqueray B, Philippe C, Cadranel J, Baud L. Reactive oxygen and nitrogen intermediates increase transforming growth factor-beta1 release from human epithelial alveolar cells through two different mechanisms. Am J Respir Cell Mol Biol 1999, 21:128-136.
91. Arsalane K, Dubois CM, Muanza T, Begin R, Boudreau F, Asselin C, Cantin AM. Transforming growth factor-beta1 is a potent inhibitor of glutathione synthesis in the lung epithelial cell line A549: transcriptional effect on the GSH rate-limiting enzyme gamma-glutamylcysteine synthetase. Am J Respir Cell Mol Biol 1997, 17:599-607.
92. Factor VM, Kiss A, Woitach JT, Wirth PJ, Thorgeirsson SS. Disruption of redox homeostasis in the transforming growth factor-alpha/c-myc transgenic mouse model of accelerated hepatocarcinogenesis. J Biol Chem 1998, 273:15846-15853. 10.1074/jbc.273.25.15846, 9624185.
93. James AJ, Penrose JF, Cazaly AM, Holgate ST, Sampson AP. Human bronchial fibroblasts express the 5-lipoxygenase pathway. Respir Res 2006, 27;7:102. 3179725, 21906390.